Raised alanine transaminase and decreased adiponectin are features of the metabolic syndrome in patients with type 2 diabetes

被引：9
|
作者：
Hickman, Ingrid J. [1 ]
Whitehead, Jonathan P. [1 ]
Prins, Johannes B. [1 ]
Macdonald, Graeme A. [1 ]
机构：
[1] Univ Queensland, Princess Alexandra Hosp, CDER, Woolloongabba, Qld 4102, Australia
来源：
DIABETES OBESITY & METABOLISM | 2007年 / 9卷 / 03期
关键词：
adiponectin; BMI; insulin resistance; liver injury; NAFLD;
D O I：
10.1111/j.1463-1326.2006.00604.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Aim: The aim of the study was to investigate the relationship between the metabolic syndrome (MS), adiponectin and abnormal liver enzymes in patients with type 2 diabetes. Methods: Fasting serum was collected from 189 patients with type 2 diabetes, adiponectin was measure using radioimmunoassay and features of the MS were assessed. Results: Mean ALT was significantly higher in patients with the MS and higher ALT was associated with lower adiponectin levels. As the number of features of MS increased, ALT increased and adiponectin decreased independent of glycaemic control. Conclusion: Hypoadiponectinemia and the MS may be linked with liver injury in patients with type 2 diabetes.
引用
收藏
页码：438 / 440
页数：3
相关论文
共 50 条
  • [1] Elevated serum alanine transaminase in patients with type 1 or type 2 diabetes mellitus
    West, J.
    Brousil, J.
    Gazis, A.
    Jackson, L.
    Mansell, P.
    Bennett, A.
    Aithal, G. P.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2006, 99 (12) : 871 - 876
  • [2] Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes
    Mojiminiyi, O. A.
    Abdella, N. A.
    Al Arouj, M.
    Ben Nakhi, A.
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 (02) : 213 - 220
  • [3] Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes
    O A Mojiminiyi
    N A Abdella
    M Al Arouj
    A Ben Nakhi
    International Journal of Obesity, 2007, 31 : 213 - 220
  • [4] Elevated Serum Alanine Transaminase (ALT) in Patients of Type 2 Diabetes Mellitus
    Shah, Nasir
    Jahangir, Saqib
    Ahmed, Naeem
    Hasan, Muhammad Saleem
    Zaidi, Yasir Abbas
    Khalid, Saira
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (11): : 3096 - 3097
  • [5] Raised Plasma Urotensin II in Type 2 Diabetes Patients Is Associated With the Metabolic Syndrome Phenotype
    Gruson, Damien
    Rousseau, Michel F.
    Ketelslegers, Jean-Marie
    Hermans, Michel P.
    JOURNAL OF CLINICAL HYPERTENSION, 2010, 12 (08): : 653 - 660
  • [6] Adiponectin, vaspin, insulin resistance and clinical expression of the metabolic syndrome in patients with type 2 diabetes
    Liu, Shiwei
    Yang, Jing
    Niu, Bo
    Wang, Tong
    ENDOCRINE JOURNAL, 2010, 57 : S409 - S410
  • [7] Orlistat improves on the features of metabolic syndrome in obese patients with type 2 diabetes
    Oh, S
    Park, CY
    Woo, JT
    Kim, YS
    Son, HY
    Lee, HC
    DIABETES, 2004, 53 : A595 - A595
  • [8] Orlistat improves on the features of metabolic syndrome in obese patients with type 2 diabetes
    Kim, YS
    Park, CY
    Son, HY
    Lee, HC
    OBESITY RESEARCH, 2004, 12 : A39 - A39
  • [9] Metabolic syndrome, adiponectin and proinflammatory status in patients with type 1 diabetes mellitus
    Timar, Romulus
    Timar, Bogdan
    Degeratu, Diana
    Serafinceanu, Cristian
    Oancea, Cristian
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2014, 42 (05) : 1131 - 1138
  • [10] FEATURES OF THE METABOLIC SYNDROME IN YOUTH WITH AND WITHOUT TYPE 2 DIABETES
    Marcovina, S.
    Dabelea, D.
    West, N.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
12345